The US Food and Drug Administration (USFDA) had conducted inspection at Somerset (New Jersey) facility in December 2018, and classified it as Official Action Indicated (OAI). ‘Official Action Indicated’, means approvals of pending applications or supplements from this site maybe withheld.
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
